Clinical Trial Update: Trial of FOLF(HA)Iri With Cetuximab in mCRC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the FOLF(HA)Iri chemotherapy regimen with cetuximab in metastatic colorectal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLF(HA)Iri

Snippet

Sponsor: Western General Hospital, Australia | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN